4FIE image
Entry Detail
PDB ID:
4FIE
Keywords:
Title:
Full-length human PAK4
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2012-06-08
Release Date:
2012-09-12
Method Details:
Experimental Method:
Resolution:
3.11 Å
R-Value Free:
0.27
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase PAK 4
Chain IDs:A, B
Chain Length:423
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER PHOSPHOSERINE
Ligand Molecules
Primary Citation
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.
Proc.Natl.Acad.Sci.USA 109 16107 16112 (2012)
PMID: 22988085 DOI: 10.1073/pnas.1214447109

Abstact

The type II p21-activated kinases (PAKs) are key effectors of RHO-family GTPases involved in cell motility, survival, and proliferation. Using a structure-guided approach, we discovered that type II PAKs are regulated by an N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline residue, and that this regulation occurs independently of activation loop phosphorylation. We determined six X-ray crystal structures of either full-length PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudosubstrate binding to the active state with phosphorylated activation loop. We show that full-length PAK4 is constitutively autoinhibited, but mutation of the pseudosubstrate releases this inhibition and causes increased phosphorylation of the apoptotic regulation protein Bcl-2/Bcl-X(L) antagonist causing cell death and cellular morphological changes. We also find that PAK6 is regulated by the pseudosubstrate region, indicating a common type II PAK autoregulatory mechanism. Finally, we find Src SH3, but not β-PIX SH3, can activate PAK4. We provide a unique understanding for type II PAK regulation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures